TICKERNERD
Menu
WATWATHealthcare · Diagnostics & Research

WAT Stock Forecast: Waters Corp. Price Predictions for 2026-2027

Last close, 9 Sept 2026
$405
+0.47% on the day

The 24 Wall Street analysts covering Waters Corp. hold a median 12-month price target of $450 — +11.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 52 of 100 as at 8 Sept 2026 — in the upper half.

Market cap
$40.2B
Ticker Nerd rank
52 / 100
Median analyst target
$450
Analysts covering
24
Revenue$1.6B+113.3% y/y
Operating income−$37.0M
Net income−$136.0M
Free cash flow$153.0M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−0.3%
1M
−0.5%
YTD
+6.6%
1Y
+34.7%
From 52W high
−3.9%
From 52W low
+42.9%
$283
$421
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

WAT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Waters Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 8 Sept 2026
52 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Volatility
86
Revisions
81
Momentum
78
Value
76
Quality
62
Growth
56
Accruals
23
Issuance
8
Size
6

Volatility (86): The share price has been relatively steady.

Issuance (8): The company has been issuing shares or taking on financing, diluting existing holders.

Size (6): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

WAT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on WAT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$300$350$400$450$500Oct 25Jan 26Apr 26Jul 26WATHigh $480Median $450Low $349

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says24 analysts
17 Buy7 Hold0 Sell
Low $349Median $450High $480

The green dot is the last close — the median target sits +11.2% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 9 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
27 Aug 2026Piper SandlerUpgradeOverweight$400 → $480
10 Aug 2026CitigroupMaintainsBuy$425 → $470
10 Aug 2026CitigroupMaintainsBuy—
5 Aug 2026BarclaysMaintainsOverweight$425 → $460
5 Aug 2026BarclaysMaintainsOverweight—
5 Aug 2026Evercore ISI GroupMaintainsOutperform—
5 Aug 2026Evercore ISI GroupMaintainsOutperform$410 → $420
5 Aug 2026RBC CapitalMaintainsOutperform—
5 Aug 2026RBC CapitalMaintainsOutperform$435 → $475
5 Aug 2026TD CowenUpgradeBuy—
5 Aug 2026TD CowenUpgradeBuy$408 → $475
5 Aug 2026Wells FargoMaintainsEqual-Weight$370 → $400
5 Aug 2026Wells FargoMaintainsEqual-Weight—
14 July 2026Goldman SachsMaintainsBuy—
14 July 2026Goldman SachsMaintainsBuy$380 → $425
9 July 2026Morgan StanleyMaintainsEqual-Weight—
9 July 2026Morgan StanleyMaintainsEqual-Weight$350 → $390
9 July 2026RBC CapitalInitiatesOutperform—
9 July 2026RBC CapitalInitiatesOutperform$435
8 July 2026GuggenheimReiteratesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. WAT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

WAT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 9 Sept 2026, Waters Corp. returned +34.7% against +18.5% for the S&P 500, dividends included.

WAT vs S&P 500, last 12 monthsTotal return, rebased to 100
90100110120130140Oct 25Jan 26Apr 26Jul 26WATS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

WAT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+0.5%
Analysts raising
21
Analysts cutting
2
Fundamentals

Waters Corp. (WAT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
102.5×

Cheaper than 7% of US stocks

Price / sales
8.5×

Cheaper than 16% of US stocks

Price / book
2.6×

Cheaper than 38% of US stocks

EV / EBITDA
31.1×

Cheaper than 9% of US stocks

Growth & margins
Revenue growth (YoY)
113.4%

Higher than 93% of US stocks

Earnings growth (YoY)
113.3%

Higher than 85% of US stocks

Gross margin
44.6%

Higher than 56% of US stocks

Operating margin
9.4%

Higher than 63% of US stocks

Net margin
3.6%

Higher than 56% of US stocks

Returns & dividend
Return on equity
1.9%

Higher than 47% of US stocks

Return on assets
3.6%

Higher than 69% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Waters Corp. (WAT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Waters Corp. has a market value of $40.2B and an enterprise value of $45.2B.

  • Revenue in the twelve months to 30 June 2026: $4.6B. The latest quarter grew 113.4% year on year.

  • Net income over the same four quarters: $166.1M, a 3.6% net margin.

  • Diluted earnings per share, trailing twelve months: $4.01.

  • Free cash flow in the twelve months to 30 June 2026: $398.8M.

  • Waters Corp. spent $14.7M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 98.2M.

  • Trailing P/E: 102.5×; forward P/E: 24.4× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Waters Corp. employs 16,000 people — $290K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 8 Sept 2026

Data provided by Twelve Data

Peers

WAT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDiagnostics & Research
CompanyMarket capTKN rank
WATWaters Corp.$40.2B
52
IDXXIDEXX Laboratories, Inc.$41.5B
92
AAgilent Technologies, Inc.$41.6B
87
IQVIQVIA Holdings, Inc.$42.7B
91
NTRANatera, Inc.$44.7B
81
ILMNIllumina, Inc.$31.9B
95
MTDMettler-Toledo International, Inc.$27.1B
91

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Waters Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest WAT news & analysis

Waters Corporation (WAT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha · 9 Sept 2026neutral

Waters Corporation presented at the Wells Fargo 21st Annual Healthcare Conference, with a transcript of the presentation published by Seeking Alpha. The coverage consists of the company's remarks at the conference.

Why it matters — A WAT watcher would care because the conference presentation offers insight into the company's current positioning and messaging to the investment community.

Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?

Zacks Investment Research · 3 Sept 2026positive

Waters (WAT) reported earnings 30 days ago, and the stock has risen 3.1% since that announcement. The article examines what may come next for the company following the earnings report.

Why it matters — A Waters watcher would care because it tracks the stock's performance since the last earnings announcement and assesses the company's near-term situation.

This Waters Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday

Benzinga · 27 Aug 2026neutral

A Benzinga report notes that top Wall Street analysts changed their outlooks on several companies, including an upgrade for Waters (WAT) that turned bullish. The piece lists this among the top three analyst upgrades for Thursday.

Why it matters — Waters investors would take note of an analyst's bullish upgrade, as shifts in analyst outlooks can reflect changing views on the company's prospects.

LetsGetChecked Powered by Fuze Health Partners with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients

Business Wire · 27 Aug 2026positive

Waters Corporation has partnered with LetsGetChecked, which now offers what it describes as the most comprehensive FDA-cleared at-home HPV cervical cancer screening tool available in the U.S. The partnership brings Waters' technology to this at-home screening product.

Why it matters — The partnership extends Waters' technology into the growing at-home cervical cancer screening market through a newly launched FDA-cleared product.

Waters Corporation to Present at the Wells Fargo Healthcare Conference

PRNewsWire · 26 Aug 2026neutral

Waters Corporation announced that CEO Udit Batra, Ph.D., will present at the upcoming Wells Fargo Healthcare Conference. The presentation is scheduled as a company event appearance.

Why it matters — A conference presentation gives investors and analysts an opportunity to hear directly from Waters' CEO about the company's outlook.

FAQ

Frequently asked questions about WAT stock

What is the WAT stock price forecast for 2026-2027?

The 24 Wall Street analysts covering Waters Corp. have a median 12-month price target of $450, with estimates ranging from $349 to $480. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is WAT stock a buy right now?

Of the 24 analysts covering Waters Corp., 17 rate it a Buy, 7 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Waters Corp. 52 out of 100 across roughly 4,600 US stocks as at 8 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank WAT?

As at 8 Sept 2026, Waters Corp. ranks 52 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (86 of 100).

Will WAT stock go up?

No one can know that. What the data says: the median 12-month target from 24 analysts implies +11.2% from the last close, and Ticker Nerd's factor model ranks Waters Corp. 52 out of 100 as at 8 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the WAT stock forecast for 2030?

No analyst covering Waters Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for WAT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $349 to $480 over the next 12 months.

How has WAT stock performed over the past year?

Waters Corp. returned +34.7% over the 12 months to 9 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Waters Corp. do?

Waters Corporation is a global analytical instruments and software company that develops technologies used to identify, separate, and measure chemical compounds in laboratory settings. Its core product portfolio includes liquid chromatography systems, mass spectrometry platforms, thermal analysis instruments, chromatography columns, laboratory informatics software, and related consumables and service offerings.

What is the latest news on WAT?

The most recent item we track (Seeking Alpha, 9 Sept 2026): "Waters Corporation (WAT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript". Waters Corporation presented at the Wells Fargo 21st Annual Healthcare Conference, with a transcript of the presentation published by Seeking Alpha. The coverage consists of the company's remarks at the conference.

Company

About Waters Corp.

Waters Corporation is a global analytical instruments and software company that develops technologies used to identify, separate, and measure chemical compounds in laboratory settings. Its core product portfolio includes liquid chromatography systems, mass spectrometry platforms, thermal analysis instruments, chromatography columns, laboratory informatics software, and related consumables and service offerings. Waters Corporation serves customers across pharmaceuticals, biotechnology, clinical research, food safety, environmental testing, materials science, and academic and government laboratories. Through its Waters and TA segments, the company supports regulated testing, quality control, and research workflows with tools designed for precision analysis and dependable laboratory performance. Headquartered in Milford, Massachusetts, Waters Corporation plays an important role in scientific measurement and analytical workflow automation across life sciences and industrial markets.

CEO Dr. Udit Batra Ph.D. · 16,000 employees · United States · https://www.waters.com